Insiders Biora Therapeutics, Inc.

Equities

BIOR

US74319F3055

Market Closed - Nasdaq Other stock markets 01:30:00 09/05/2024 am IST			5-day change	1st Jan Change
0.7161 ^USD	-3.28%		+11.54%	-46.96%

30/04	Biora Therapeutics, Inc. Announces Completion of Multiple-Ascending Dose Cohorts for Clinical Trial of BT-600	CI
04/04	Biora Therapeutics, Inc. Achieves Positive Interim Results for Clinical Trial of BT-600, Advancing NaviCap Platform Development	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Biora Therapeutics, Inc. Appoints Jeffrey A. Ferrell as Director	16/23/16	CI
Biora Therapeutics Inc Appoints Dr. Ariella Kelman as Chief Medical Officer	01/23/01	CI
Biora Therapeutics, Inc. Announces Surbhi Sarna Is Not Standing for Re-Election	28/23/28	CI
Biora Therapeutics, Inc.Appoints Bruce Sands as Chair of Its Clinical Advisory Board	07/22/07	CI
Biora Therapeutics, Inc. Announces Board Appointment	16/22/16	CI
Progenity, Inc. Announces the Appointment of Paul Shabram as Senior Vice President, Technical Operations	25/22/25	CI
Progenity to Change Name to Biora Therapeutics in Q2	12/22/12	MT
Progenity, Inc. Announces Departure of Damon Silvestry	18/22/18	CI
Progenity, Inc. Appoints Jeffrey Alter as Chairman of Board of Directors	11/21/11	CI
Progenity Names Adi Mohanty Chief Executive Officer	09/21/09	MT
Progenity, Inc. Appoints Adi Mohanty as Chief Executive Officer	09/21/09	CI
Progenity, Inc. Appoints Adi Mohanty to Its Board of Directors	09/21/09	CI
Progenity, Inc. Announces Appointment of Jill Howe to Its Board of Directors	04/21/04	CI
Progenity, Inc. Announces Resignation of Harry Stylli as Member and Chairman of the Board of Directors	02/21/02	CI
Progenity, Inc. Announces Board Changes	30/21/30	CI
Progenity, Inc Establishes Inflammatory Bowel Disease Clinical Advisory Board	17/21/17	CI
Progenity Announces Appointment of Damon Silvestry as Chief Operating Officer	26/20/26	CI
Progenity, Inc. Appoints Troy Seelye as Chief Information Officer	30/20/30	CI
Progenity, Inc. Promotes Sami Shihabi as Chief Commercial Officer	22/19/22	CI
Progenity Appoints Brian Kotzin to its Board of Directors	21/19/21	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Biora Therapeutics, Inc.

Equities

BIOR

US74319F3055

Insiders

Filters